Type 1 diabetes: open trials in Norway

• NCT07222137

  A Study of Baricitinib (LY3009104) for the Delay of Stage 3 Type 1 Diabetes in At-Risk Children and Adults

  Trial Treatment · Phase 3 · Eli Lilly and Company

  Helse Bergen HF, Bergen · Akershus University Hospital, Loerenskog · Oslo University Hospital HF, Oslo · Helse Stavanger HF, Stavanger

  Registry updated 2026-11-04

• NCT07222332

  A Study of Baricitinib (LY3009104) to Preserve Beta Cell Function in Children and Adults Newly Diagnosed With Type 1 Diabetes (BARICADE-PRESERVE)

  Trial Treatment · Phase 3 · Eli Lilly and Company

  Helse Fonna HF, Haugesund · Akershus University Hospital, Loerenskog · Oslo Universitetssykehus HF, Oslo · Helse Stavanger HF, Stavanger · St. Olavs hospital HF, Trondheim

  Registry updated 2026-11-04

• NCT05663515

  A Pan-European Post-Authorisation Safety Study: Risk of Pancreatic Cancer Among Type 2 Diabetes Patients Who Initiated Exenatide as Compared With Those Who Initiated Other Non-Glucagon-Like Peptide 1 Receptor Agonists Based Glucose Lowering Drugs

  Research · AstraZeneca

  Bergen

  Registry updated 2026-09-24

• NCT04786262

  A Safety, Tolerability, and Efficacy Study of VX-880 and VX-017 in Participants With Type 1 Diabetes

  Trial Treatment · Phase 3 · Vertex Pharmaceuticals Incorporated

  Oslo University Hospital HF, Oslo

  Registry updated 2026-09-01

All Type 1 diabetes trials and the map

This page is not medical advice. Talk to your doctor before contacting a trial.

Report an error